Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Department of Endocrinology and Internal Medicine and Medical Research Laboratories, Aarhus University Hospital, Aarhus, Denmark.
Am J Med Genet C Semin Med Genet. 2020 Jun;184(2):279-293. doi: 10.1002/ajmg.c.31799. Epub 2020 Jun 3.
47,XXX (triple X) and Turner syndrome (45,X) are sex chromosomal abnormalities with detrimental effects on health with increased mortality and morbidity. In karyotypical normal females, X-chromosome inactivation balances gene expression between sexes and upregulation of the X chromosome in both sexes maintain stoichiometry with the autosomes. In 47,XXX and Turner syndrome a gene dosage imbalance may ensue from increased or decreased expression from the genes that escape X inactivation, as well as from incomplete X chromosome inactivation in 47,XXX. We aim to study genome-wide DNA-methylation and RNA-expression changes can explain phenotypic traits in 47,XXX syndrome. We compare DNA-methylation and RNA-expression data derived from white blood cells of seven women with 47,XXX syndrome, with data from seven female controls, as well as with seven women with Turner syndrome (45,X). To address these questions, we explored genome-wide DNA-methylation and transcriptome data in blood from seven females with 47,XXX syndrome, seven females with Turner syndrome, and seven karyotypically normal females (46,XX). Based on promoter methylation, we describe a demethylation of six X-chromosomal genes (AMOT, HTR2C, IL1RAPL2, STAG2, TCEANC, ZNF673), increased methylation for GEMIN8, and four differentially methylated autosomal regions related to four genes (SPEG, MUC4, SP6, and ZNF492). We illustrate how these changes seem compensated at the transcriptome level although several genes show differential exon usage. In conclusion, our results suggest an impact of the supernumerary X chromosome in 47,XXX syndrome on the methylation status of selected genes despite an overall comparable expression profile.
47,XXX(三倍 X)和特纳综合征(45,X)是性染色体异常,对健康有不利影响,导致死亡率和发病率增加。在核型正常的女性中,X 染色体失活平衡了性别间的基因表达,而两性中 X 染色体的上调维持了与常染色体的化学计量平衡。在 47,XXX 和特纳综合征中,由于逃避 X 失活的基因表达增加或减少,以及 47,XXX 中不完全的 X 染色体失活,可能会导致基因剂量失衡。我们旨在研究全基因组 DNA 甲基化和 RNA 表达变化如何解释 47,XXX 综合征的表型特征。我们比较了来自七位 47,XXX 综合征女性的白细胞的 DNA 甲基化和 RNA 表达数据,与七位女性对照者的数据,以及七位特纳综合征(45,X)女性的数据。为了解决这些问题,我们探索了来自七位 47,XXX 综合征女性、七位特纳综合征女性和七位核型正常女性(46,XX)的血液中的全基因组 DNA 甲基化和转录组数据。基于启动子甲基化,我们描述了六个 X 染色体基因(AMOT、HTR2C、IL1RAPL2、STAG2、TCEANC、ZNF673)的去甲基化、GEMIN8 的甲基化增加以及四个与四个基因(SPEG、MUC4、SP6 和 ZNF492)相关的差异甲基化常染色体区域。我们说明了这些变化如何在转录组水平上得到补偿,尽管几个基因表现出不同的外显子使用。总之,我们的结果表明,尽管整体表达谱相似,但 47,XXX 综合征中多余的 X 染色体对选定基因的甲基化状态有影响。